Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.160
+0.020 (0.64%)
Nov 20, 2024, 4:00 PM EST - Market closed
Atea Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for AVIR stock has a target of 6.88, which predicts an increase of 117.72% from the current stock price of 3.16.
Analyst Consensus: Hold
* Price targets were last updated on Aug 13, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for AVIR is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 2 | 2 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $2 → $6.88 | Sell → Hold | Upgrades | $2 → $6.88 | +117.72% | Aug 13, 2024 |
JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Aug 10, 2023 |
JP Morgan | JP Morgan | Hold Maintains $12 → $8 | Hold | Maintains | $12 → $8 | +153.16% | Mar 16, 2023 |
SVB Leerink | SVB Leerink | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +89.87% | Jan 27, 2023 |
Morgan Stanley | Morgan Stanley | Sell Maintains $7 → $4 | Sell | Maintains | $7 → $4 | +26.58% | Jan 24, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
7.73M
EPS This Year
-2.26
from -1.63
EPS Next Year
-1.56
from -2.26
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | 22.3M | 925.3M |
Avg | n/a | 7.7M | 321.3M |
Low | n/a | n/a | 16.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | 11,864.2% |
Avg | - | - | 4,054.9% |
Low | - | - | 115.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -2.22 | -1.49 | 0.70 |
Avg | -2.26 | -1.56 | -0.32 |
Low | -2.27 | -1.61 | -1.27 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.